Breast / Breasts / Cancer / Drugs

FDA OKs First Targeted Drug for HER2-Low Breast Cancer

Posted on: Aug 6, 2022 | Posted by: Master Doctor

The FDA has approved the first targeted therapy for unresectable/metastatic breast cancer in the newly defined low-HER2 subtype. The approval for trastuzumab deruxtecan...

Other Posts from Master Doctor

FDA OKs First Gene Therapy for Beta-Thalassemia
Walensky criticizes COVID-19 response, announces plan to transform CDC
Can Musical Tests Detect Mental Deterioration in Old Age?
Experts warn: Centralized digital currencies could be used to control how people behave
Mystery deepens surrounding mass FISH KILL in Europe's Oder River
Meta to cosponsor event with Pfizer celebrating communist China
‘The ultimate legacy decision': Why Clarkson must choose North Melbourne
China's golden dragons flee to avoid US scrutiny
Laser Hair Removal for Men
Trauma Therapy Is in the Spotlight; Psychologists Explain What It Is - and Who It's For
Post-COVID Neurologic, Psychiatric Symptoms May Persist for 2 Years
EXCLUSIVE: Natural News releases post-vaccine clot ICP-MS elemental analysis results, comparing clots to human blood. findings reveal these clots are NOT "blood" clots
Combined monogenic, polygenic risk prediction spurs changes in CAD management
Am I Protected Against Polio?
Tuna Tartare with Cucumber and Avocado
Acceptance of Medicaid varies greatly among cancer care facilities
Kindergarten Teacher Shares Heartbreaking Video Of Bare Classroom
AAP updates recommendations for helmet use
Worse health literacy linked to greater preoperative symptom severity in shoulder patients
Watch A 9-Year-Old Boy Get A Sewing Machine For His Birthday